Skip to content

Serum Leukocyte cell-derived chemotaxin 2 level and its association with coronary artery disease: a retrospective study.

Serum Leukocyte cell-derived chemotaxin 2 level and its association with coronary artery disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033590
Enrollment
Unknown
Registered
2020-06-06
Start date
2020-06-08
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

case series:Nil

Sponsors

Department of Cardiology, Union Hospital affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-100 years; 2. Patients with stable angina pectoris, unstable angina pectoris or positive treadmill exercise test with diagnostic coronary angiography indications were examined in our hospital. 3. Patients willing to participate in the experiment.

Exclusion criteria

Exclusion criteria: 1. Patients with elevated troponin; 2. Patients with autoimmune diseases; 3. Patients with malignant tumors; 4. Patients with chronic or acute inflammatory diseases; 5. Patients with asthma and severe heart failure (NYHA grade 3 and 4); 6. Patients with liver dysfunction and chronic kidney disease.

Design outcomes

Secondary

MeasureTime frame
serum creatinine;n-terminal B-type natriuretic peptide;high-sensitivity C-reactive protein;glycosylated hemoglobin;serum low-density lipoprotein cholesterol;serum high density lipoprotein cholesterol;triglyceride;

Primary

MeasureTime frame
leukocyte cell-derived chemotaxin 2;gensini scores of coronary artery;

Countries

China

Contacts

Public ContactLianglong Chen

Union Hospital Affiliated to Fujian Medical University

chenlianglongfjxh@126.com+86 13365910396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026